Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070610 | SCV001235871 | uncertain significance | Fanconi anemia | 2020-02-11 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with glycine at codon 372 of the FANCM protein (p.Glu372Gly). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and glycine. This variant is present in population databases (rs762845761, ExAC 0.001%). This variant has not been reported in the literature in individuals with FANCM-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001772305 | SCV002003219 | uncertain significance | not provided | 2024-11-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002489710 | SCV002776340 | uncertain significance | Spermatogenic failure 28; Premature ovarian failure 15 | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004738154 | SCV005356693 | uncertain significance | FANCM-related disorder | 2024-06-10 | no assertion criteria provided | clinical testing | The FANCM c.1115A>G variant is predicted to result in the amino acid substitution p.Glu372Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD and interpreted as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/863609/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |